EPIQ Capital Group - Unicorn Nest

EPIQ Capital Group

EPIQ Capital Group

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

United States, San Francisco


EPIQ Capital Group is a well known and established VC, which was founded in 2018. This investor is located in North America, United States. The the headquarters of this VC is in San Francisco.

This VC was founded by Chad Boeding. We also identified another 4 core personnel in our database.

Tenstorrent, Cortexyme are among the most popular portfolio start-ups of the fund. We can highlight the most popular investment areas for this fund, such as Biotechnology, Medical. In addition, there is 1 more industry where it has achieved success. The country of its foundation and the country of its most frequent investments coincides - United States. Besides this, the fund also invested in 1 other country. The fund has an exact preference in the amount of founders of companies in its portfolio. Moreover, a start-up needs to be 4-5 years old to get investment from this fund.

The usual method for the fund is to invest in rounds with 6 other investors. Aside from EPIQ Capital Group, start-ups are often funded by Dolby Family Ventures, Takeda Ventures, Pfizer. The fund often co-invests with Vulcan Capital, Verily, Takeda Ventures.

The fund generally invests in less than 2 deals every year. The fund's activity peaked in 2019. Besides, in 2019 the fund was active. The most exits for the fund occurred in 2019. The most common rounds for this fund are in the range of 10 - 50 millions dollars.

Year Founded


Fund Activity


Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name: epiqcg.com; User name format in descending order of probability: first

Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Investments per Year [average amount of rounds in which fund participates each year]


Average Multiplicator [the average ratio of the last valuation of portfolio startups to their total amount of financing raised]


Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]

0.4 years

Funds Investing in Previous

Dolby Family Ventures, Takeda Ventures, Pfizer

Funds Investing Together

Vulcan Capital, Verily, Takeda Ventures

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: